Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration |
| |
| Authors: | Scarisbrick Isobel A Linbo Rachel Vandell Alexander G Keegan Mark Blaber Sachiko I Blaber Michael Sneve Diane Lucchinetti Claudia F Rodriguez Moses Diamandis Eleftherios P |
| |
| Institution: | Program for Molecular Neuroscience, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. scarisbrick.isobel@mayo.edu |
| |
| Abstract: | Tissue kallikrein KLK1 and the kallikrein-related peptidases KLK2-15 are a subfamily of serine proteases that have defined or proposed roles in a range of central nervous system (CNS) and non-CNS pathologies. To further understand their potential activity in multiple sclerosis (MS), serum levels of KLK1, 6, 7, 8 and 10 were determined in 35 MS patients and 62 controls by quantitative fluorometric ELISA. Serum levels were then correlated with Expanded Disability Status Scale (EDSS) scores determined at the time of serological sampling or at last clinical follow-up. Serum levels of KLK1 and KLK6 were elevated in MS patients (p
|
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
